glp 1 suicidal ideation Exploration of the potential association between GLP-1 receptor agonists and or self-injurious behaviors: a pharmacovigilance study based on the FDA Adverse Event Reporting System database | BMC Medicine Glucagon-like peptide-1 receptor agonists and

Absorption barriers : Many of these compounds have poor skin penetration profiles

[DOI] [PubMed] [Google Scholar] Martinelli I., Tomassoni D., Roy P., Di Cesare Mannelli L., Amenta F., Tayebati S.K

Success depends on careful patient selection, proper protocol implementation, and ongoing monitoring

Diagnostic overshadowing describes when a healthcare provider refuses to provide a diagnosis for your concerns until you lose weight, or focuses your entire appointment on weight loss instead of treating your concerns

Half-lives range from sub-day (liraglutide) to multi-day (semaglutide, tirzepatide), and molecular weight ranges from ~3.5 kDa (liraglutide, cagrilintide) to ~4.8 kDa (tirzepatide)

Even semaglutide , despite being dramatically more potent, takes 4-5 weeks of dose escalation before most users reach therapeutic levels